Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)
| Autor: | Conconi, A. *, Martinelli, G., Lopez-Guillermo, A., Zinzani, P.L., Ferreri, A.J.M., Rigacci, L., Devizzi, L., Vitolo, U., Luminari, S., Cavalli, F., Zucca, E. |
|---|---|
| Zdroj: | In Annals of Oncology March 2011 22(3):689-695 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|